TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Injectable Semaglutide Shortage Forces Physicians to Pivot
WEBFeb 5, 2024 · And across the Atlantic, the European Medicines Agency has also put out a notice on a shortage of injectable semaglutide—specifically the Ozempic prefilled pens at doses of 0.25, 0.5, and 1 mg—due to both burgeoning demand and manufacturing issues. The agency said the shortfall is expected to continue through this year.
Good News for CV Recovery After COVID-19 Vaccine Myocarditis
WEBAug 29, 2024 · The 558 patients with postvaccine myocarditis were on average younger (25.9 years) and more often male (84%) compared with the 298 and 3,779 patients, respectively, with post-COVID-19 (31.0 years; 67% male) and conventional myocarditis (28.3 years; 79% male). About two-thirds (67%) of postvaccine myocarditis occurred after the patient received ...
Nitrates and Erectile Dysfunction Meds? Increasingly Common, …
WEBApr 20, 2022 · By L.A. McKeown. Despite widely publicized warnings about the potential interaction between nitrates prescribed for angina and oral (phosphodiesterase type 5) PDE5 inhibitors taken for erectile dysfunction, a Danish study suggests that prescriptions for the latter have steadily increased over the last 20 years in men who take nitrates, but ...
Blood Pressure Insights in COVID-19: Watch for Drops and RAAS …
WEBSep 10, 2020 · Here, Baher Al-Abbasi, MD (University of Miami/JFK Medical Center, Atlantis, FL), and colleagues noted increased in-hospital mortality in 172 COVID-19 patients taking ACE inhibitors or ARBs compared with those not taking the drugs (33% vs 13%; P = 0.003), as well as increased likelihood of admission to the …
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With …
WEBOct 26, 2023 · The study was simultaneously published in the Journal of the American College of Cardiology. QoL Endpoints. For the study, researchers looked at the first 350 patients with severe TR randomized in TRILUMINATE to tricuspid TEER (n = 175) or medical therapy (n = 175). At 1 month, patients treated with TEER saw significantly improved health status ...
New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides
WEBAug 21, 2019 · For managing hypertriglyceridemia (200-499 mg/dL), the AHA experts state that prescription-strength omega-3 fatty acids, either with eicosapentaenoic acid (EPA) or EPA plus docosapentaenoic acid (DHA), would be expected to yield a 20% to 30% reduction in triglycerides without any increase in LDL cholesterol.
The Lutonix® 035 Drug Coated Balloon is the First and Only
WEBOct 10, 2014 · MURRAY HILL, N.J.-- C. R. Bard, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix® 035 Drug Coated Balloon (DCB) Catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length in native vascular disease of the superficial femoral or popliteal arteries with reference ...